Your session is about to expire
← Back to Search
Niraparib for Melanoma
Study Summary
This trial is studying how well niraparib works in treating patients with advanced melanoma that has progressed after other treatments.
- Metastatic Melanoma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 37 Patients • NCT03207347Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the precedent studies for Niraparib?
"Currently, 96 clinical trials for Niraparib are active with 13 of them in Phase 3. While some of the research is based out of Washington D.C., there are 2645 total facilities conducting these studies."
Are there still enrollees needed for this clinical trial?
"As of 10/15/2021, this study detailed on clinicaltrials.gov is still searching for individuals to participate. The original posting date was 3/20/2019."
Has the United States Food and Drug Administration cleared Niraparib for use?
"Niraparib's safety was given a score of 2. This is because, although Phase 2 trials offer some data suggesting that the drug is safe, there are no such studies yet which confirm its efficacy."
How many individuals are involved in this experiment?
"That is correct, the listing on clinicaltrials.gov affirms that this research project is actively looking for volunteers. The trial was first posted on March 20th, 2019 and updated as recently as October 15th, 2021. A total of 41 individuals are needed across 1 locations."
Does this clinical trial break new ground?
"Niraparib has had 96 clinical trials thus far, with the first taking place in 2016. Myriad Genetics, Inc. sponsored the initial study which 733 people took part in. It completed Phase 3 and was approved for drugs. Since then, 17 more studies have been conducted."
Share this study with friends
Copy Link
Messenger